Organon (OGN) Cash from Operations (2020 - 2026)

Organon (OGN) posted quarterly Cash from Operations of 225000000.0 for Q1 2026, up 200.0% year-over-year from 75000000.0 in Q1 2025, and up 59.57% on a QoQ basis from 141000000.0 in Q4 2025.

Organon (OGN) Cash from Operations (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Cash from Operations for 7 consecutive years, with 225000000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Operations rose 200.0% year-over-year to 225000000.0; the TTM figure through Mar 2026 stood at 850000000.0 (down 9.38% YoY), while the FY2025 annual figure was 700000000.0, down 25.45% from the prior year.
  • Cash from Operations came in at 225000000.0 for Q1 2026 at Organon, up from 141000000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 397000000.0 in Q4 2023, with the low at 27000000.0 in Q2 2023.
  • Average Cash from Operations over 5 years is 207117647.06, with a median of 220000000.0 recorded in 2025.
  • Across the five-year window, Cash from Operations tumbled 90.54% in 2022 and soared 1129.63% in 2024, its largest moves.
  • Year by year, Cash from Operations stood at 267000000.0 in 2022, then surged by 48.69% to 397000000.0 in 2023, then slipped by 1.76% to 390000000.0 in 2024, then slumped by 63.85% to 141000000.0 in 2025, then surged by 59.57% to 225000000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 225000000.0, 141000000.0, and 264000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.33 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.51 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.83 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.92 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 2.54 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.62 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 225.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 225.00 Mn
Mar 31, 2026 225.00 Mn
Dec 31, 2025 141.00 Mn
Dec 31, 2025 141.00 Mn
Sep 30, 2025 264.00 Mn
Sep 30, 2025 264.00 Mn
Jun 30, 2025 220.00 Mn
Jun 30, 2025 220.00 Mn
Mar 31, 2025 75.00 Mn
Mar 31, 2025 75.00 Mn
Dec 31, 2024 390.00 Mn
Dec 31, 2024 390.00 Mn
Sep 30, 2024 141.00 Mn
Sep 30, 2024 141.00 Mn
Jun 30, 2024 332.00 Mn
Jun 30, 2024 332.00 Mn
Mar 31, 2024 76.00 Mn
Mar 31, 2024 76.00 Mn
Dec 31, 2023 397.00 Mn
Dec 31, 2023 397.00 Mn